Home Newsletters Cancer Stem Cell News MCM2 Promotes the Stemness and Sorafenib Resistance of Hepatocellular Carcinoma Cells via...

MCM2 Promotes the Stemness and Sorafenib Resistance of Hepatocellular Carcinoma Cells via Hippo Signaling

0
Stemness-related molecules and phenotypes were examined to evaluate the impact of MCM2 on stemness. The expression levels of key molecules of the hippo signaling pathway together with downstream target genes were examined to evaluate the effect of MCM2 on hippo signaling.
[Cell Death Discovery]
Full Article
Exit mobile version